Not Tagged
adaptive biotechnology
['cll', 'adaptive ']
at #ash22, join at this product theater: the clinical actionability of clonoseq mrd assessment in lymphoid malignancies. clonoseq is fda-cleared to assess mrd in cll, mm and b-all. for further info: 
The FDA-cleared clonoSEQ Assay from @AdaptiveBiotech detects and tracks MRD in patients w/ myeloma, B-ALL, or CLL. Policies: https://t.co/6zaCbi4pmE.